261 related articles for article (PubMed ID: 34994851)
21. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
22. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
23. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
24. Progressive multifocal leukoencephalopathy: what's new?
Focosi D; Marco T; Kast RE; Maggi F; Ceccherini-Nelli L; Petrini M
Neuroscientist; 2010 Jun; 16(3):308-23. PubMed ID: 20479473
[TBL] [Abstract][Full Text] [Related]
25. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
Brain Nerve; 2007 Feb; 59(2):125-37. PubMed ID: 17380777
[TBL] [Abstract][Full Text] [Related]
26. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS; Koralnik IJ
Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
[TBL] [Abstract][Full Text] [Related]
27. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.
Kaiserman J; O'Hara BA; Haley SA; Atwood WJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239927
[TBL] [Abstract][Full Text] [Related]
28. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.
Marshall LJ; Major EO
J Neuroimmune Pharmacol; 2010 Sep; 5(3):404-17. PubMed ID: 20401541
[TBL] [Abstract][Full Text] [Related]
29. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
Boesl F; Allers K; Herm J; Scheider T; Franke C
J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of progressive multifocal leukoencephalopathy--revisited.
White MK; Khalili K
J Infect Dis; 2011 Mar; 203(5):578-86. PubMed ID: 21227915
[TBL] [Abstract][Full Text] [Related]
32. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
34. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
35. Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Lambert N; Dauby S; Dive D; Sadzot B; Maquet P
Emerg Infect Dis; 2022 Jan; 28(1):253-6. PubMed ID: 34856110
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A
Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916
[TBL] [Abstract][Full Text] [Related]
37. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
38. [Neuropathology of progressive multifocal leukoencephalopathy].
Murayama S; Saito Y
No To Shinkei; 2007 Feb; 59(2):119-24. PubMed ID: 17315753
[TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
40. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
